Shanghai Engineering Research Center of Organ Repair, Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), School of Medicine, Shanghai University, Nantong 226011, China; Cardiac Regeneration and Ageing Lab, Institute of Cardiovascular Sciences, School of Life Science, Shanghai University, Shanghai, 200444, China.
Shanghai Engineering Research Center of Organ Repair, Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), School of Medicine, Shanghai University, Nantong 226011, China.
EBioMedicine. 2021 Dec;74:103713. doi: 10.1016/j.ebiom.2021.103713. Epub 2021 Nov 24.
Exercise can protect myocardial infarction (MI) and downregulate cardiac Homeodomain-Interacting Protein Kinase 2 (HIPK2). However, the role of HIPK2 in MI is unclear.
HIPK2 mice and miR-222 rats, HIPK2 inhibitor (PKI1H) and adeno-associated virus serotype 9 (AAV9) carrying miR-222 were applied in the study. Animals were subjected to running, swimming, acute MI or post-MI remodeling. HIPK2 inhibition and P53 activator were used in neonatal rat cardiomyocytes (NRCMs) and human embryonic stem cell-derived cardiomyocytes (hESC-CMs) subjected to oxygen glucose deprivation/reperfusion (OGD/R). Serum miR-222 levels were analyzed in healthy people and MI patients that were survival or readmitted to the hospital and/or died.
Cardiac HIPK2 protein levels were reduced by exercise while increased in MI. In vitro, HIPK2 suppression by lentiviral vectors or inhibitor prevented apoptosis induced by OGD/R in NRCMs and hESC-CMs. HIPK2 inhibitor-treated mice and HIPK2 mice reduced infarct size after acute MI, and preserved cardiac function in MI remodeling. Mechanistically, protective effect against apoptosis by HIPK2 suppression was reversed by P53 activators. Furthermore, increasing levels of miR-222, targeting HIPK2, protected post-MI cardiac dysfunction, whereas cardiac dysfunction post-MI was aggravated in miR-222 rats. Moreover, serum miR-222 levels were significantly reduced in MI patients, as well as in MI patients that were readmitted to the hospital and/or died compared to those not.
Exercise-induced HIPK2 suppression attenuates cardiomyocytes apoptosis and protects MI by decreasing P-P53. Inhibition of HIPK2 represents a potential novel therapeutic intervention for MI.
This work was supported by the grants from National Key Research and Development Project (2018YFE0113500 to JJ Xiao), National Natural Science Foundation of China (82020108002, 81722008, and 81911540486 to JJ Xiao, 81400647 to MJ Xu, 81800265 to YJ Liang), Innovation Program of Shanghai Municipal Education Commission (2017-01-07-00-09-E00042 to JJ Xiao), the grant from Science and Technology Commission of Shanghai Municipality (18410722200 and 17010500100 to JJ Xiao), the "Dawn" Program of Shanghai Education Commission (19SG34 to JJ Xiao), Shanghai Sailing Program (21YF1413200 to QL Zhou). JS is supported by Horizon2020 ERC-2016-COG EVICARE (725229).
运动可以保护心肌梗死(MI)并下调心脏同源域相互作用蛋白激酶 2(HIPK2)。然而,HIPK2 在 MI 中的作用尚不清楚。
应用 HIPK2 敲除(HIPK2-/-)小鼠和 miR-222 大鼠、HIPK2 抑制剂(PKI1H)和携带 miR-222 的腺相关病毒血清型 9(AAV9)进行研究。动物进行跑步、游泳、急性 MI 或 MI 后重塑。在经历氧葡萄糖剥夺/再灌注(OGD/R)的新生大鼠心肌细胞(NRCMs)和人胚胎干细胞衍生的心肌细胞(hESC-CMs)中使用 HIPK2 抑制和 P53 激活剂。分析健康人群和 MI 患者的血清 miR-222 水平,这些患者为存活或再次入院和/或死亡。
运动可降低心脏 HIPK2 蛋白水平,而 MI 时则增加。在体外,慢病毒载体或抑制剂抑制 HIPK2 可防止 NRCMs 和 hESC-CMs 中的 OGD/R 诱导的细胞凋亡。HIPK2 抑制剂处理的小鼠和 HIPK2-/-小鼠可减少急性 MI 后的梗死面积,并在 MI 重塑过程中保持心脏功能。机制上,HIPK2 抑制的抗细胞凋亡作用被 P53 激活剂逆转。此外,增加靶向 HIPK2 的 miR-222 水平可保护 MI 后心脏功能障碍,而 miR-222 大鼠的 MI 后心脏功能障碍加重。此外,与未入院的患者相比,MI 患者以及再次入院和/或死亡的 MI 患者的血清 miR-222 水平明显降低。
运动诱导的 HIPK2 抑制通过减少 P-P53 来减轻心肌细胞凋亡并保护 MI。抑制 HIPK2 可能代表 MI 的一种潜在新的治疗干预措施。
本工作得到国家重点研发计划(2018YFE0113500 给 JJ 肖)、国家自然科学基金(82020108002、81722008、81911540486 给 JJ 肖,81400647 给 MJ 徐,81800265 给 YJ 梁)、上海市教育委员会创新计划(2017-01-07-00-09-E00042 给 JJ 肖)、上海市科学技术委员会资助(18410722200 和 17010500100 给 JJ 肖)、上海市教委“曙光计划”(19SG34 给 JJ 肖)和上海市扬帆计划(21YF1413200 给 QL 周)的支持。JS 得到了 Horizon2020 ERC-2016-COG EVICARE(725229)的支持。